EPIZYME INC's ticker is EPZM and the CUSIP is 29428V104. A total of 89 filers reported holding EPIZYME INC in Q4 2015. The put-call ratio across all filers is 0.33 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $520,000 | -17.7% | 50,378 | 0.0% | 0.94% | +0.5% |
| Q2 2019 | $632,000 | +1.3% | 50,378 | 0.0% | 0.94% | +10.5% |
| Q1 2019 | $624,000 | -72.8% | 50,378 | -73.4% | 0.85% | -52.4% |
| Q1 2016 | $2,298,000 | +5.8% | 189,564 | +39.8% | 1.78% | +23.7% |
| Q4 2015 | $2,173,000 | +266.4% | 135,627 | +194.3% | 1.44% | +339.1% |
| Q3 2015 | $593,000 | -65.9% | 46,079 | -36.3% | 0.33% | -76.2% |
| Q2 2015 | $1,737,000 | +91.3% | 72,379 | +49.7% | 1.38% | +80.8% |
| Q1 2015 | $908,000 | +69.7% | 48,339 | +70.6% | 0.76% | +43.9% |
| Q4 2014 | $535,000 | – | 28,339 | – | 0.53% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RP Management, LLC | 31,833,334 | $47,750,000 | 19.42% |
| MPM BioImpact LLC | 3,425,202 | $3,939,000 | 1.06% |
| Palo Alto Investors LP | 6,774,541 | $7,791,000 | 0.60% |
| Foresite Capital Management I, LLC | 143,759 | $165,000 | 0.29% |
| PLATINUM INVESTMENT MANAGEMENT LTD | 6,603,870 | $7,594,000 | 0.23% |
| Rock Springs Capital Management LP | 7,267,696 | $8,358,000 | 0.21% |
| BP PLC | 24,687 | $28,000 | 0.16% |
| NewGen Asset Management Ltd | 250,000 | $288,000 | 0.13% |
| GSA CAPITAL PARTNERS LLP | 467,836 | $538,000 | 0.07% |
| Frazier Life Sciences Management, L.P. | 739,369 | $850,000 | 0.07% |